BioSpace News Archive

Job Trends

GELITA & Geltor Sign Letter of Intent to Commercialize First Animal-Free Biodesigned Collagen for Dietary Supplements, a Market with Huge Growth Potential

In the halls of the SupplySide West Expo, officials from both GELITA and Geltor signed a letter of intent for developing, producing and marketing the first ingestible animal-free collagen proteins – to be launched in late 2020.

October 17, 2019
·
4 min read
Lone Star Bio

MGI Demonstrates Success of New CoolMPS™ Sequencing Chemistry on PCR-free DNBSEQ™ Platform

Results from early access collaborators show high quality and reproducibility

October 17, 2019
·
2 min read
Business

Stallergenes Greer and Anergis Initiate New Study to Predict Efficacy of Second-Generation Allergen Immunotherapy

Second-generation Allergen Immunotherapy based on Anergis Contiguous Overlapping Peptides (COP) linked to Virosomes will be tested by Stallergenes Greer using its therapeutic model of birch pollen allergy.

October 17, 2019
·
3 min read
Business

LHC Group Announces Third Quarter 2019 Earnings Release and Conference Call Dates

LHC Group, Inc. announced details for the release of its results for the third quarter and nine months ended September 30, 2019..

October 17, 2019
·
1 min read
Pharm Country

Arvinas to Present Initial Data from Ongoing Clinical Trials and a Pipeline Update at the 2nd Targeted Protein Degradation Summit

Arvinas Inc.,, a biotechnology company creating a new class of drugs based on targeted protein degradation, announced it will be participating in multiple sessions of the 2nd Targeted Protein Degradation Summit.

October 17, 2019
·
5 min read
Drug Development

QED and Parent Company BridgeBio Announce Preclinical Data Supporting Tolerability and Activity of Low-dose Infigratinib in Treating Achondroplasia

Infigratinib showed improvements in nine measures of bone development in the Fgfr3[Y367C/+] mouse model of achondroplasia at a low dose

October 17, 2019
·
8 min read
Pharm Country

Palatin Presents On Pl8177 Oral Colon Delivery Formulation For Ulcerative Colitis At The 7Th CPC Symposium On Peptide Therapeutics

Dr. Dodd was invited by symposium organizers to speak about the challenges of peptide drug development.

October 17, 2019
·
2 min read
Business

Verastem Oncology to Announce Third Quarter 2019 Financial Results and Corporate Update on October 29, 2019

Verastem, Inc. announced that the Company will host a conference call and webcast on Tuesday, October 29, 2019 at 4:30 p.m.

October 17, 2019
·
1 min read
Business

RTI Surgical® Schedules Third Quarter 2019 Earnings Call for October 31, 2019

RTI will host a conference call and simultaneous audio webcast to discuss third quarter results at 9:00 a.m. ET the same day.

October 17, 2019
·
2 min read
Pharm Country

Foamix Announces FDA Acceptance of its New Drug Application for FMX103 Minocycline Foam for the Treatment of Moderate-to-Severe Papulopustular RosaceaPDUFA Target Action Date of June 2nd, 2020

Foamix Pharmaceuticals Ltd. (Nasdaq: FOMX), a clinical stage specialty pharmaceutical company focused on developing and commercializing proprietary topical therapies to address unmet needs in dermatology, today announced that the U.S. Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for FMX103 (minocycline topical foam 1.5%) topical foam.

October 17, 2019
·
5 min read